Tenaris S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on April 4, 2025, serves as a notice for the Annual General Meeting (AGM) and Extraordinary General Meeting (EGM) of Tenaris S.A. shareholders, scheduled for May 6, 2025, in Luxembourg. The filing accompanies the Shareholder Meeting Brochure and Proxy Statement. The primary financial reporting period referenced is the fiscal year ended December 31, 2024.
Key Financial Metrics
- Net Profit (2024): Approximately US$1,469.8 million.
- Proposed Annual Dividend: US$0.83 per share (US$1.66 per ADR), totaling approximately US$0.9 billion.
- Dividend Structure: Includes an interim dividend of US$0.27 per share paid in November 2024; the remaining balance of US$0.56 per share is proposed for payment on May 21, 2025.
- Share Capital: Current issued capital is US$1,162,757,528 (1,162,757,528 shares).
- Share Buybacks: The Company repurchased 71,679,768 shares for US$1.2 billion (Nov 2023–Aug 2024) and 36,862,132 shares for approximately US$700 million (Nov 2024–Mar 2025).
- Auditor Fees (2025): Proposed aggregate fees for Forvis Mazars are approximately US$1,397,500.
Material Changes and Corporate Actions
The filing details significant capital structure changes to be voted upon at the EGM:
- Share Cancellation: Proposal to cancel 90,762,598 ordinary shares held in treasury, reducing issued share capital by US$90,762,598 to US$1,071,994,930.
- Authorized Capital Renewal: Renewal of the authorized share capital (up to US$2.5 billion) and related waivers of pre-emptive subscription rights for five years.
- Auditor Change: Appointment of Forvis Mazars as the new statutory auditor for the fiscal year ending December 31, 2025, following a competitive tender process.
Guidance, Outlook, and Management Commentary
Management emphasizes that stakeholder participation is key to long-term success. The Board justifies the renewal of authorized share capital and waivers of pre-emptive rights as necessary to maintain flexibility for acquisitions, investments, and strategic financing without delay. The Board also highlights the importance of flexible equity compensation plans (up to 1.5% of issued capital) to attract and retain talent. No specific forward-looking revenue or earnings guidance is provided in this filing; the focus is on capital allocation and governance.
Investor Verification Checklist
- Voting Deadlines: Verify the Shareholders' Record Time (April 22, 2025, 24:00 CET) and the Proxy Form deadline (April 28, 2025, 24:00 CET) to ensure voting rights are preserved.
- Dividend Record Date: Confirm the record date for the proposed "Dividend Balance" payment of US$0.56 per share, payable May 21, 2025.
- Capital Reduction Impact: Assess the impact of the proposed cancellation of ~90.8 million shares on earnings per share (EPS) and total share count.
- Auditor Transition: Review the rationale for switching from the previous auditor to Forvis Mazars and the approved fee structure.
- Pre-emptive Rights Waiver: Understand the implications of the renewed waiver of pre-emptive rights, which allows the Board to issue shares without offering them first to existing shareholders in specific scenarios (e.g., M&A, employee compensation).